In fact, in normal breast tissue, glucocorticoids have been reported to induce the synthesis of aromatase (Chen, 1998): an enzyme that catalyses the conversion of androgens to oestrogens, and is the target site for a new class of breast cancer chemotherapy. Here, CYP19A1 is linked to breast carcinoma.